Garenoxacin Mesylate Hydrate is a potent quinolone antibiotic belonging to the fluoroquinolone class, primarily utilized for treating complicated urinary tract infections caused by susceptible gram-positive… Read more
Garenoxacin Mesylate Hydrate is a potent quinolone antibiotic belonging to the fluoroquinolone class, primarily utilized for treating complicated urinary tract infections caused by susceptible gram-positive and gram-negative bacteria. By inhibiting bacterial DNA gyrase and topoisomerase IV, this compound effectively prevents DNA replication within the pathogen. Laboratories require high-quality reference standards of Garenoxacin Mesylate Hydrate, along with its related pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds, to conduct rigorous analytical testing and method validation. These critical materials are essential for impurity profiling, ensuring accurate identification and quantification during pharmaceutical quality control processes. By utilizing these precise standards, researchers can reliably monitor degradation products and metabolic pathways, ultimately supporting the development and safety assessment of antibacterial pharmaceutical formulations.